![](/img/cover-not-exists.png)
Antitumor activity of an anti-gastrin releasing peptide (GRP) murine monoclonal antibody (2A11). Phase II trial and in vitro correlation with peptide and receptor expression
Volume:
11
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/0169-5002(94)93785-0
Date:
June, 1994
File:
PDF, 156 KB
english, 1994